1. Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300. (24th July 2018) Authors: Bang, Y -J; Ruiz, E Yañez; Van Cutsem, E; Lee, K -W; Wyrwicz, L; Schenker, M; Alsina, M; Ryu, M -H; Chung, H -C; Evesque, L; Al-Batran, S -E; Park, S H; Lichinitser, M; Boku, N; Moehler, M H; Hong, J; Xiong, H; Hallwachs, R; Conti, I; Taieb, J Journal: Annals of oncology Issue: Volume 29:Number 10(2018) Page Start: 2052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗